Last reviewed 2026-04-20 · How we verify
Home › Drugs › Children's Hospital of Fudan University › Rivaroxaban Oral Tablet [Xarelto] Rivaroxaban Oral Tablet [Xarelto]
At a glance
Generic name Rivaroxaban Oral Tablet [Xarelto] Also known as Xarelto Sponsor Children's Hospital of Fudan University Modality Small molecule Phase FDA-approved
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
Drug Landscape https://druglandscape.com/drug/rivaroxaban-oral-tablet-xarelto · Machine-readable: markdown · JSON · Editorial policy: /editorial-policy
Not medical advice. Information on this page is collated from primary regulatory and clinical-trial sources for research purposes. It is not a substitute for consultation with a licensed healthcare professional. See our editorial policy for sourcing and methodology.